JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5176
Janux Therapeutics
JANX
$1.04B
| $190K | ﹤0.01% |
17,736
-130,873
| -88% | -$1.13M |
2021 Q2
10 quarters
|
|
5177
Accuray
ARAY
$33.6M
| $190K | ﹤0.01% |
67,225
+3,836
| +6% | +$10.5K |
2014 Q3
37 quarters
|
|
5178
Organogenesis Holdings
ORGO
$171M
| $190K | ﹤0.01% |
46,464
-1,582
| -3% | -$4.43K |
2019 Q1
19 quarters
|
|
5179
ARS Pharmaceuticals
SPRY
$405M
| $190K | ﹤0.01% |
34,649
+369
| +1% | +$1.62K |
2021 Q1
11 quarters
|
|
5180
Park Aerospace
PKE
$662M
| $190K | ﹤0.01% |
12,907
-305
| -2% | -$4.56K |
2014 Q4
36 quarters
|
|
5181
LCNB Corp
LCNB
$270M
| $190K | ﹤0.01% |
12,027
+5,167
| +75% | +$76K |
2017 Q4
24 quarters
|
|
5182
CALL
Starwood Property Trust
STWD
$4.83B
| $189K | ﹤0.01% |
+9,000
| New | +$177K |
2023 Q4
0 quarters
|
|
5183
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.32B
| $189K | ﹤0.01% |
1,809
+3
| +0.2% | +$281 |
2022 Q4
4 quarters
|
|
5184
The ONE Group
STKS
$49.4M
| $189K | ﹤0.01% |
30,835
+11,128
| +56% | +$55.1K |
2021 Q2
10 quarters
|
|
5185
Chemung Financial Corp
CHMG
$395M
| $188K | ﹤0.01% |
3,782
+999
| +36% | +$44.3K |
2022 Q4
4 quarters
|
|
|
DOO
5186
Bombardier Recreational Products
DOO
$3.99B
| $188K | ﹤0.01% |
2,619
-6,057
| -70% | -$424K |
2023 Q3
1 quarter
|
|
5187
Willis Lease Finance
WLFC
$966M
| $187K | ﹤0.01% |
11,460
+5,199
| +83% | +$77.3K |
2023 Q1
3 quarters
|
|
5188
Rigel Pharmaceuticals
RIGL
$881M
| $186K | ﹤0.01% |
12,822
-8,583
| -40% | -$87.8K |
2016 Q2
30 quarters
|
|
5189
Hooker Furnishings Corp
HOFT
$141M
| $185K | ﹤0.01% |
7,104
-59
| -0.8% | -$1.18K |
2016 Q3
29 quarters
|
|
5190
Erasca
ERAS
$5.16B
| $185K | ﹤0.01% |
86,835
+4,726
| +6% | +$9.97K |
2021 Q3
9 quarters
|
|
5191
C&F Financial
CFFI
$320M
| $185K | ﹤0.01% |
2,712
+583
| +27% | +$34K |
2023 Q2
2 quarters
|
|
|
PBPB
5192
DELISTED
Potbelly
PBPB
| $185K | ﹤0.01% |
17,739
| – | – |
2017 Q3
25 quarters
|
|
5193
Simplify Multi-QIS Alternative ETF
QIS
$42.6M
| $184K | ﹤0.01% |
+7,454
| New | +$191K |
2023 Q4
0 quarters
|
|
5194
Axogen
AXGN
$2.19B
| $184K | ﹤0.01% |
26,897
-914
| -3% | -$5.08K |
2017 Q4
24 quarters
|
|
5195
Spok Holdings
SPOK
$228M
| $183K | ﹤0.01% |
11,837
-268
| -2% | -$4.12K |
2022 Q4
4 quarters
|
|
|
MIN
5196
Aberdeen Intermediate Income Fund
MIN
$265M
| $183K | ﹤0.01% |
68,341
+63,750
| +1,389% | +$170K |
2022 Q4
4 quarters
|
|
|
MRSN
5197
DELISTED
Mersana Therapeutics
MRSN
| $183K | ﹤0.01% |
3,153
-7,528
| -70% | -$303K |
2017 Q2
26 quarters
|
|
|
BCYC
5198
Bicycle Therapeutics
BCYC
$237M
| $183K | ﹤0.01% |
10,106
-58,393
| -85% | -$966K |
2021 Q1
11 quarters
|
|
|
MITT
5199
TPG Mortgage Investment Trust
MITT
$183M
| $182K | ﹤0.01% |
28,705
+28,680
| +114,720% | +$156K |
2015 Q4
32 quarters
|
|
5200
Latham Group
SWIM
$754M
| $182K | ﹤0.01% |
69,243
-8,268
| -11% | -$20.5K |
2021 Q2
10 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.